Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Frontotemporal Disorders Treatment Market, by Region, 2020-2030 (USD Billion)
1.2.2. Frontotemporal Disorders Treatment Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Frontotemporal Disorders Treatment Market, by Disease Indication, 2020-2030 (USD Billion)
1.2.4. Frontotemporal Disorders Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Frontotemporal Disorders Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Frontotemporal Disorders Treatment Market Dynamics
3.1. Frontotemporal Disorders Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of dementia and other frontotemporal disorders
3.1.1.2. Rising funding by the government as well as non-government organizations
3.1.2. Market Challenges
3.1.2.1. Unavailability of skilled professionals
3.1.2.2. Stringent government regulations
3.1.3. Market Opportunities
3.1.3.1. Rising emphasis on research and development activities
3.1.3.2. Increasing drug approvals
Chapter 4. Global Frontotemporal Disorders Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Frontotemporal Disorders Treatment Market, by Drug Class
5.1. Market Snapshot
5.2. Global Frontotemporal Disorders Treatment Market by Drug Class, Performance – Potential Analysis
5.3. Global Frontotemporal Disorders Treatment Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Frontotemporal Disorders Treatment Market, Sub Segment Analysis
5.4.1. Cognitive Enhancers
5.4.2. Antipsychotics
5.4.3. Antidepressants
5.4.4. CNS Stimulants
5.4.5. Other Drug Classes
Chapter 6. Global Frontotemporal Disorders Treatment Market, by Disease Indication
6.1. Market Snapshot
6.2. Global Frontotemporal Disorders Treatment Market by Disease Indication, Performance – Potential Analysis
6.3. Global Frontotemporal Disorders Treatment Market Estimates & Forecasts by Disease Indication 2020-2030 (USD Billion)
6.4. Frontotemporal Disorders Treatment Market, Sub Segment Analysis
6.4.1. Frontotemporal Dementia
6.4.2. Primary Progressive Aphasia
6.4.3. Movement Disorders
Chapter 7. Global Frontotemporal Disorders Treatment Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Frontotemporal Disorders Treatment Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Frontotemporal Disorders Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Frontotemporal Disorders Treatment Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Frontotemporal Disorders Treatment Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Frontotemporal Disorders Treatment Market, Regional Market Snapshot
8.4. North America Frontotemporal Disorders Treatment Market
8.4.1. U.S. Frontotemporal Disorders Treatment Market
8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
8.4.1.2. Disease Indication breakdown estimates & forecasts, 2020-2030
8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Frontotemporal Disorders Treatment Market
8.5. Europe Frontotemporal Disorders Treatment Market Snapshot
8.5.1. U.K. Frontotemporal Disorders Treatment Market
8.5.2. Germany Frontotemporal Disorders Treatment Market
8.5.3. France Frontotemporal Disorders Treatment Market
8.5.4. Spain Frontotemporal Disorders Treatment Market
8.5.5. Italy Frontotemporal Disorders Treatment Market
8.5.6. Rest of Europe Frontotemporal Disorders Treatment Market
8.6. Asia-Pacific Frontotemporal Disorders Treatment Market Snapshot
8.6.1. China Frontotemporal Disorders Treatment Market
8.6.2. India Frontotemporal Disorders Treatment Market
8.6.3. Japan Frontotemporal Disorders Treatment Market
8.6.4. Australia Frontotemporal Disorders Treatment Market
8.6.5. South Korea Frontotemporal Disorders Treatment Market
8.6.6. Rest of Asia Pacific Frontotemporal Disorders Treatment Market
8.7. Latin America Frontotemporal Disorders Treatment Market Snapshot
8.7.1. Brazil Frontotemporal Disorders Treatment Market
8.7.2. Mexico Frontotemporal Disorders Treatment Market
8.8. Middle East & Africa Frontotemporal Disorders Treatment Market
8.8.1. Saudi Arabia Frontotemporal Disorders Treatment Market
8.8.2. South Africa Frontotemporal Disorders Treatment Market
8.8.3. Rest of Middle East & Africa Frontotemporal Disorders Treatment Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Johnson & Johnson
9.3.3. Sanofi S.A.
9.3.4. Eli Lilly and Company
9.3.5. GlaxoSmithKline Plc.
9.3.6. Novartis AG
9.3.7. Mylan N.V.
9.3.8. Merck & Company, Inc.
9.3.9. AstraZeneca plc.
9.3.10. Allergen plc
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/